Aiman Abdel-Malek, PhD
Dr. Aiman Abdel-Malek served as the Executive Vice President and Chief Technology Officer at Insulet Corporation (NASDAQ: PODD) until April 2019. From March 2016 to February 2018, he was Insulet's Senior Vice President, Advanced Technology and Engineering. At Insulet, Aiman’s vision for a securely connected diabetes management system, controlled by users’ smartphones, was realized. Working collaboratively with the rest of Insulet’s leadership team, Insulet developed, FDA cleared, and market launched the Omnipod DASHTM system. This user-centered designed product platform enables secure Bluetooth connected Omnipod Insulin management system, controlled by smartphone. DASHTM was also recognized as the first Insulin pump to receive DTSec Cybersecurity Certification in diabetes.
Prior to joining Insulet, Aiman served as President of Frictionless Life Analytics, Inc., a business development and healthcare technology company which enables the growth of start-up ventures focused on Internet of Things (IoT) platforms solutions. From 2012 to 2015, he served as Vice President of Engineering at Qualcomm Life, Inc., a mobile healthcare solutions Qualcomm company. From 1988 to 2012, he held various roles at General Electric, including GM - Global Services Technology at GE Healthcare where he launched the first GE predictive services offerings. He brings over 20 years of experience as a senior executive, leading healthcare business teams to develop break-through technology-based business solutions. He holds a Bachelor of Science in Systems and Biomedical Engineering from Cairo University and a Ph.D. in Biomedical Engineering from the University of Southern California. Dr. Abdel-Malek holds over 30 patents and publications and is a keynote speaker at various digital healthcare, secure IoT and mobile digital healthcare forums.